New epilepsy drug shows promise in Long-Term safety trial
Disease control
Recruiting now
This study is testing the long-term safety and effectiveness of an experimental drug called CB03-154 for people with focal epilepsy. About 144 adults who completed a previous study on this drug will take it for up to a year. Researchers will track side effects and changes in seiz…
Phase: PHASE2 • Sponsor: Shanghai Zhimeng Biopharma, Inc. • Aim: Disease control
Last updated May 06, 2026 16:14 UTC